The gut–liver axis calibrates PEDF production for ISC homeostasis

Ying Huang; Xinran Wang; Lulu Sun

doi:10.52601/bpr.2024.240904

Article Contents

Article Navigation > Biophysics Reports > 2024 > In Press

Ying Huang, Xinran Wang, Lulu Sun. The gut–liver axis calibrates PEDF production for ISC homeostasis. Biophysics Reports. doi: 10.52601/bpr.2024.240904

Citation:

Ying Huang, Xinran Wang, Lulu Sun. The gut–liver axis calibrates PEDF production for ISC homeostasis. Biophysics Reports. doi: 10.52601/bpr.2024.240904

Ying Huang, Xinran Wang, Lulu Sun. The gut–liver axis calibrates PEDF production for ISC homeostasis. Biophysics Reports. doi: 10.52601/bpr.2024.240904

Citation:

Ying Huang, Xinran Wang, Lulu Sun. The gut–liver axis calibrates PEDF production for ISC homeostasis. Biophysics Reports. doi: 10.52601/bpr.2024.240904

PDF (365 KB)

The gut–liver axis calibrates PEDF production for ISC homeostasis

doi: 10.52601/bpr.2024.240904

Ying Huang^{1, 2},
Xinran Wang^{1, 2},
Lulu Sun^{1, 2
,
,}

1.
State Key Laboratory of Female Fertility Promotion, Department of Endocrinology and Metabolism, Peking University Third Hospital, Beijing 100191, China
2.
Institute of Advanced Clinical Medicine, Peking University, Beijing 100191, China

More Information

Corresponding author: lulusun@bjmu.edu.cn (L. Sun)
Received Date: 27 March 2024
Accepted Date: 03 April 2024

Available Online: 20 May 2024

Abstract

FullText(HTML)

References(16)

References

Andreu-Agulló C, Morante-Redolat JM, Delgado AC, Fariñas I (2009) Vascular niche factor PEDF modulates Notch-dependent stemness in the adult subependymal zone. Nat Neurosci 12(12): 1514−1523 doi: 10.1038/nn.2437

Brook N, Brook E, Dharmarajan A, Chan A, Dass CR (2020) Pigment epithelium-derived factor regulation of neuronal and stem cell fate. Exp Cell Res 389(2): 111891. https://doi.org/10.1016/j.yexcr.2020.111891

Chen L, Jiao T, Liu W, Luo Y, Wang J, Guo X, Tong X, Lin Z, Sun C, Wang K, He Y, Zhang Y, Xu H, Wang J, Zuo J, Ding Q, He S, Gonzalez FJ, Xie C (2022) Hepatic cytochrome P450 8B1 and cholic acid potentiate intestinal epithelial injury in colitis by suppressing intestinal stem cell renewal. Cell Stem Cell 29(9): 1366−1381 doi: 10.1016/j.stem.2022.08.008

Gäbele E, Dostert K, Hofmann C, Wiest R, Schölmerich J, Hellerbrand C, Obermeier F (2011) DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. J Hepatol 55(6): 1391−1399 doi: 10.1016/j.jhep.2011.02.035

Han H, Jiang Y, Wang M, Melaku M, Liu L, Zhao Y, Everaert N, Yi B, Zhang H (2023) Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut–liver axis. Crit Rev Food Sci Nutr 63(12): 1689−1706 doi: 10.1080/10408398.2021.1966738

Hegyi P, Maléth J, Walters JR, Hofmann AF, Keely SJ (2018) Guts and gall: bile acids in regulation of intestinal epithelial function in health and disease. Physiol Rev 98(4): 1983−2023 doi: 10.1152/physrev.00054.2017

Jones GR, Bain CC, Fenton TM, Kelly A, Brown SL, Ivens AC, Travis A, Cook PC, MacDonald AS (2018) Dynamics of colon monocyte and macrophage activation during colitis. Front Immunol 9: 2764. https://doi.org/10.3389/fimmu.2018.02764

Kim G, Chen Z, Li J, Luo J, Castro-Martinez F, Wisniewski, Cui K, Wang Y, Sun J, Ren X, Crawford SE, Becerra SP, Zhu J, Liu T, Wang S, Zhao K, Wu C (2024) Gut-liver axis calibrates intestinal stem cell fitness. Cell 187(4): 914−930 doi: 10.1016/j.cell.2024.01.001

Koning M, Herrema H, Nieuwdorp M, Meijnikman AS (2023) Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies. Gut Microbes 15(1): 2226922. https://doi.org/10.1080/19490976.2023.2226922

Luo Y, Xie C, Brocker CN, Fan J, Wu X, Feng L, Wang Q, Zhao J, Lu D, Tandon M, Cam M, Krausz KW, Liu W, Gonzalez FJ (2019) Intestinal PPARα protects against colon carcinogenesis via regulation of methyltransferases DNMT1 and PRMT6. Gastroenterology 157(3): 744−759 doi: 10.1053/j.gastro.2019.05.057

Qi Y, Jiang C, Tanaka N, Krausz KW, Brocker C, Fang ZZ, Bredell BX, Shah YM, Gonzalez FJ (2014) PPARα-dependent exacerbation of experimental colitis by the hypolipidemic drug fenofibrate. Am J Physiol Gastrointest Liver Physiol 307(5): G564−573 doi: 10.1152/ajpgi.00153.2014

van der Flier LG, Clevers H (2009) Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol 71: 241−260 doi: 10.1146/annurev.physiol.010908.163145

Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG (2001) The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 48: 206−211 doi: 10.1136/gut.48.2.206

Wu N, Sun H, Zhao X, Zhang Y, Tan J, Qi Y, Wang Q, Ng M, Liu Z, He L, Niu X, Chen L, Liu Z, Li H.-B, Zeng YA, Roulis M, Liu D, Cheng J, Zhou B, Ng LG, Zou D, Ye Y, Flavell RA, Ginhoux F, Su B (2021) MAP3K2-regulated intestinal stromal cells define a distinct stem cell niche. Nature 592(7855): 606−610 doi: 10.1038/s41586-021-03283-y

Yang M, Xu D, Liu Y, Guo X, Li W, Guo C, Zhang H, Gao Y, Mao Y, Zhao J (2015) Combined serum biomarkers in non-invasive diagnosis of non-alcoholic steatohepatitis. PloS One 10(6): e0131664. https://doi.org/10.1371/journal.pone.0131664

Yilmaz Y, Eren F, Ayyildiz T, Colak Y, Kurt R, Senates E, Tuncer I, Dolar E, Imeryuz N (2011) Serum pigment epithelium-derived factor levels are increased in patients with biopsy-proven nonalcoholic fatty liver disease and independently associated with liver steatosis. Clin Chim Acta Int J Clin Chem 412(23-24): 2296−2299 doi: 10.1016/j.cca.2011.08.025

Supplements(0)

Relative Articles

Cited By

Proportional views